UNSPSC 51131820: Coagulation factor vii

This classification denotes an antifibrinolytic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4156XVB4QD. European Medicines Agency schedules Coagulation factor viii in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Indices SUB32741 and SUB13811MIG. Coagulation factor vii bears US NLM identifiers UMLS ID C0015502 and NCI Concept Code C16570.

UNSPSC 51131820 Coagulation factor vii is a Commodity code with no recent state and local procurement activity aligned to its actual scope. The single recent opportunity tagged under this code—Sourcewell's RFP #061626 for law enforcement equipment, posted May 12, 2026 with response due June 16, 2026—is plainly unrelated to pharmaceutical coagulation factors and represents a mislabeling in the contracting system rather than authentic demand for this product line. The code shows no measurable activity in state and local government procurement for coagulation factor vii itself.

State and local health departments, Medicaid agencies, hospital systems, and public health authorities that procure blood clotting therapies typically source them through established pharmaceutical vendor contracts, group purchasing organizations, or specialty distributor frameworks rather than through open solicitations tagged to commodity codes in procurement systems. If pursuit is being evaluated, confirm current demand signals directly with target customer agencies and their pharmacy or materials management functions before investing in capability development.